What is remdesivir? Gilead Sciences drug reportedly shows promise treating coronavirus
April 17, 2020 / Nathan Bomey, USA TODAY
A Gilead Sciences antiviral drug is reportedly showing promise for treatment of the coronavirus.
Remdesivir is causing “rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week” in patients at a Chicago hospital, medical site STAT reported.
The story contributed to a surge in stocks Friday and a jump in Gilead’s stock price, which rose 8.1% to $82.74 at 10:14 a.m.
“The entire world has been waiting for results from Gilead’s clinical trials, and positive results would likely lead to fast approvals by the Food and Drug Administration and other regulatory agencies,” STAT reported. “If safe and effective, it could become the first approved treatment against the disease.”
Remdesivir is one of numerous drugs under development to treat or cure the coronavirus. Clinical trials are conducted to ensure safety and efficacy, and there’s no guarantee the Chicago hospital’s results will be replicated elsewhere.
